- Home
- GPRE vs GOSS Comparison
GPRE vs GOSS Comparison
Compare GPRE & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRE
- GOSS
- Stock Information
- Founded
- GPRE 2004
- GOSS 2015
- Country
- GPRE United States
- GOSS United States
- Employees
- GPRE N/A
- GOSS N/A
- Industry
- GPRE Major Chemicals
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- GPRE Industrials
- GOSS Health Care
- Exchange
- GPRE Nasdaq
- GOSS Nasdaq
- Market Cap
- GPRE 289.7M
- GOSS 262.5M
- IPO Year
- GPRE N/A
- GOSS 2019
- Fundamental
- Price
- GPRE $7.21
- GOSS $1.36
- Analyst Decision
- GPRE Buy
- GOSS Strong Buy
- Analyst Count
- GPRE 7
- GOSS 3
- Target Price
- GPRE $10.42
- GOSS $7.33
- AVG Volume (30 Days)
- GPRE 2.0M
- GOSS 2.6M
- Earning Date
- GPRE 08-05-2025
- GOSS 08-11-2025
- Dividend Yield
- GPRE N/A
- GOSS N/A
- EPS Growth
- GPRE N/A
- GOSS N/A
- EPS
- GPRE N/A
- GOSS N/A
- Revenue
- GPRE $2,463,097,000.00
- GOSS $124,590,000.00
- Revenue This Year
- GPRE $2.90
- GOSS N/A
- Revenue Next Year
- GPRE $1.54
- GOSS $91.14
- P/E Ratio
- GPRE N/A
- GOSS N/A
- Revenue Growth
- GPRE N/A
- GOSS N/A
- 52 Week Low
- GPRE $3.14
- GOSS $0.66
- 52 Week High
- GPRE $18.14
- GOSS $1.55
- Technical
- Relative Strength Index (RSI)
- GPRE 84.31
- GOSS 56.18
- Support Level
- GPRE $5.60
- GOSS $1.20
- Resistance Level
- GPRE $5.88
- GOSS $1.33
- Average True Range (ATR)
- GPRE 0.37
- GOSS 0.09
- MACD
- GPRE 0.13
- GOSS -0.01
- Stochastic Oscillator
- GPRE 97.16
- GOSS 48.98
About GPRE Green Plains Inc.
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.